|
|||||
|
|
New Feature: See Wall Street analyst ratings directly on Finviz charts for deeper context into price action.
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| CAS | DOLAN SCOTT J | President and CEO | Dec 15 '14 | Buy | 6.90 | 13,700 | 94,530 | 181,677 | Dec 17 12:39 PM |
| CAS | DOLAN SCOTT J | President and CEO | Nov 10 '14 | Buy | 7.10 | 300 | 2,130 | 167,977 | Nov 12 03:34 PM |
| CAS | DOLAN SCOTT J | President and CEO | Nov 04 '14 | Buy | 7.05 | 14,000 | 98,700 | 167,677 | Nov 06 04:13 PM |
| CAS | DOLAN SCOTT J | President and CEO | Sep 12 '14 | Buy | 9.75 | 14,900 | 145,275 | 134,054 | Sep 15 11:39 AM |
| CAS | DOLAN SCOTT J | President and CEO | Aug 11 '14 | Buy | 9.00 | 14,000 | 125,996 | 106,554 | Aug 13 09:32 AM |
| CAS | DOLAN SCOTT J | President and CEO | Aug 12 '14 | Buy | 9.00 | 12,600 | 113,400 | 119,154 | Aug 13 09:32 AM |
| CAS | DOLAN SCOTT J | President and CEO | May 02 '14 | Buy | 12.88 | 23,900 | 307,832 | 92,254 | May 06 12:52 PM |
| CAS | DOLAN SCOTT J | President and CEO | May 05 '14 | Buy | 12.57 | 300 | 3,771 | 92,554 | May 06 12:52 PM |
| CAS | DOLAN SCOTT J | President and CEO | Dec 06 '13 | Buy | 13.73 | 14,900 | 204,577 | 58,885 | Dec 09 10:37 AM |
| CAS | DOLAN SCOTT J | President and CEO | Nov 01 '13 | Buy | 14.33 | 7,650 | 109,624 | 43,985 | Nov 04 01:20 PM |
| CAS | DOLAN SCOTT J | President and CEO | Aug 21 '13 | Buy | 16.47 | 4,600 | 75,763 | 16,712 | Aug 22 01:20 PM |
| CAS | DOLAN SCOTT J | President and CEO | Jun 14 '13 | Buy | 17.01 | 4,700 | 79,947 | 12,112 | Jun 17 11:45 AM |
| CAS | DOLAN SCOTT J | President and CEO | Mar 15 '13 | Buy | 17.18 | 6,000 | 103,080 | 7,412 | Mar 18 01:35 PM |
| CAS | DOLAN SCOTT J | President and CEO | Mar 07 '13 | Option Exercise | 0.00 | 2,059 | 0 | 2,059 | Mar 08 05:22 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite